AAAAAA

   
Results: 1-9 |
Results: 9
Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration
Authors: Koelemij, R Hagenaars, M Ensink, NG Eggermont, AMM Van De Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: R. Koelemij et al., Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration, SC J IMMUN, 53(3), 2001, pp. 277-281
The phenotypic heterogeneity of human natural killer cells: Presence of atleast 48 different subsets in the peripheral blood
Authors: Jonges, LE Albertsson, P Van Vlierberghe, RLP Ensink, NG Johannson, BR Van de Velde, CJH Fleuren, GJ Nannmark, U Kuppen, PJK
Citation: Le. Jonges et al., The phenotypic heterogeneity of human natural killer cells: Presence of atleast 48 different subsets in the peripheral blood, SC J IMMUN, 53(2), 2001, pp. 103-110
Caspase-3 activity as a prognostic factor in colorectal carcinoma
Authors: Jonges, LE Nagelkerke, JF Ensink, NG van der Velde, EA Tollenaar, RAEM Fleuren, GJ van de Velde, CJH Morreau, H Kuppen, PJK
Citation: Le. Jonges et al., Caspase-3 activity as a prognostic factor in colorectal carcinoma, LAB INV, 81(5), 2001, pp. 681-688
Recombinant adenoviral vectors have adjuvant activity and stimulate T cellresponses against tumor cells
Authors: Geutskens, SB van der Eb, MM Plomp, AC Jonges, LE Cramer, SJ Ensink, NG Kuppen, PJK Hoeben, RC
Citation: Sb. Geutskens et al., Recombinant adenoviral vectors have adjuvant activity and stimulate T cellresponses against tumor cells, GENE THER, 7(16), 2000, pp. 1410-1416
Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model
Authors: Hagenaars, M Ensink, NG Eggermont, AMM van der Velde, EA van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model, CANCER IMMU, 48(10), 2000, pp. 561-568
The development of novel mouse monoclonal antibodies against the CC531 ratcolon adenocarcinoma
Authors: Hagenaars, M Koelemij, R Ensink, NG van Eendenburg, JDH van Vlierberghe, RLP Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., The development of novel mouse monoclonal antibodies against the CC531 ratcolon adenocarcinoma, CLIN EXP M, 18(4), 2000, pp. 281-289
The microscopic anatomy of experimental rat CC531 colon tumour metastases:Consequences for immunotherapy?
Authors: Hagenaars, M Ensink, NG Basse, PH Hokland, M Nannmark, U Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., The microscopic anatomy of experimental rat CC531 colon tumour metastases:Consequences for immunotherapy?, CLIN EXP M, 18(2), 2000, pp. 189-196
NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis
Authors: Jonges, LE Giezeman-Smits, KM van Vlierberghe, RLP Ensink, NG Hagenaars, M Joly, E Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: Le. Jonges et al., NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis, IMMUNOBIOL, 202(4), 2000, pp. 326-338
The development of a bi-specific anti-CD 161AxAnti-tumor antibody for rat NK cell targeting
Authors: Hagenaars, M Ensink, NG Jonges, LE Chambers, WH Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., The development of a bi-specific anti-CD 161AxAnti-tumor antibody for rat NK cell targeting, IMMUNOBIOL, 200(1), 1999, pp. 31-48
Risultati: 1-9 |